Skip to content
10-Q

Quarterly Report

NUTRA PHARMA CORP. NPHC

0001493152-26-015334

← back to feed
Filed
Apr 6, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Apr 6, 2026 7.16B sh
Shares Diluted Q3 2025 · Sep 30, 2025 7.82B sh
Shares Diluted Q3 2025 · Sep 30, 2025 7.75B sh
Shares Diluted Q3 2025 · Sep 30, 2024 7.66B sh
Shares Diluted Q3 2025 · Sep 30, 2024 7.65B sh
Capex Q3 2025 · Sep 30, 2025 $26.05K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$944.15K
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$245.75K
Long Term Debt Q3 2025 · Sep 30, 2025 $137.55K
Long Term Debt Q3 2025 · Dec 31, 2024 $140.22K
Short Term Investments Q3 2025 · Sep 30, 2025 $17.6K
Short Term Investments Q3 2025 · Dec 31, 2024 $17.6K
Stockholders Equity Q3 2025 · Sep 30, 2025 −$16.35M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$15.83M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$14.81M
Stockholders Equity Q3 2025 · Sep 30, 2024 −$14.82M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$14.56M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$13.77M
Current Liabilities Q3 2025 · Sep 30, 2025 $16.92M
Current Liabilities Q3 2025 · Dec 31, 2024 $15.27M
Total Liabilities Q3 2025 · Sep 30, 2025 $17.06M
Total Liabilities Q3 2025 · Dec 31, 2024 $15.41M
Current Assets Q3 2025 · Sep 30, 2025 $545.11K
Current Assets Q3 2025 · Dec 31, 2024 $374.84K
Total Assets Q3 2025 · Sep 30, 2025 $709.85K
Total Assets Q3 2025 · Dec 31, 2024 $599.5K
Eps Diluted Q3 2025 · Sep 30, 2025 $0.00
Eps Diluted Q3 2025 · Sep 30, 2025 $0.00
Eps Diluted Q3 2025 · Sep 30, 2024 $0.00
Eps Diluted Q3 2025 · Sep 30, 2024 $0.00
Eps Basic Q3 2025 · Sep 30, 2025 $0.00
Eps Basic Q3 2025 · Sep 30, 2025 $0.00
Eps Basic Q3 2025 · Sep 30, 2024 $0.00
Eps Basic Q3 2025 · Sep 30, 2024 $0.00
Sga Expense Q3 2025 · Sep 30, 2025 $420.65K
Sga Expense Q3 2025 · Sep 30, 2025 $1.2M
Sga Expense Q3 2025 · Sep 30, 2024 $255.45K
Sga Expense Q3 2025 · Sep 30, 2024 $860.29K
Net Income Q3 2025 · Sep 30, 2025 −$523.52K
Net Income Q3 2025 · Sep 30, 2025 −$1.56M
Net Income Q3 2025 · Sep 30, 2024 −$260.68K
Net Income Q3 2025 · Sep 30, 2024 −$1.05M
Operating Income Q3 2025 · Sep 30, 2025 −$356.08K
Operating Income Q3 2025 · Sep 30, 2025 −$996.42K
Operating Income Q3 2025 · Sep 30, 2024 −$184.75K
Operating Income Q3 2025 · Sep 30, 2024 −$699.55K
Gross Profit Q3 2025 · Sep 30, 2025 $64.58K
Gross Profit Q3 2025 · Sep 30, 2025 $208.54K
Gross Profit Q3 2025 · Sep 30, 2024 $70.69K
Gross Profit Q3 2025 · Sep 30, 2024 $160.74K
Revenue Q3 2025 · Sep 30, 2025 $70.24K
Revenue Q3 2025 · Sep 30, 2025 $228.75K
Revenue Q3 2025 · Sep 30, 2024 $74.99K
Revenue Q3 2025 · Sep 30, 2024 $164.44K
Cost Of Revenue Q3 2025 · Dec 31, 2024 $240.56K